On Tuesday, Bausch Health Companies Inc (NYSE: BHC) was -5.57% drop from the session before settling in for the closing price of $7.18. A 52-week range for BHC has been $4.25 – $9.85.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 52.33%. When this article was written, the company’s average yearly earnings per share was at -8.95%. With a float of $327.15 million, this company’s outstanding shares have now reached $369.75 million.
Considering the fact that the conglomerate employs 20700 people, you should pay attention to its efficiency factor.
Bausch Health Companies Inc (BHC) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Bausch Health Companies Inc stocks. The insider ownership of Bausch Health Companies Inc is 11.53%, while institutional ownership is 67.66%. The most recent insider transaction that took place on Sep 08 ’25, was worth 97,735. In this transaction EVP, General Counsel of this company sold 13,370 shares at a rate of $7.31, taking the stock ownership to the 499,585 shares. Before that another transaction happened on Sep 08 ’25, when Company’s Officer proposed sale 13,370 for $7.31, making the entire transaction worth $97,735.
Bausch Health Companies Inc (BHC) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted 1.12 earnings per share (EPS) during the time that was better than consensus figure (set at 1.02) by 0.1. Wall Street market experts anticipate that the next fiscal year will bring earnings of 1.66 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -8.95% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 1.85% during the next five years compared to 52.33% growth over the previous five years of trading.
Bausch Health Companies Inc (NYSE: BHC) Trading Performance Indicators
You can see what Bausch Health Companies Inc (BHC) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.98. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.25. Likewise, its price to free cash flow for the trailing twelve months is 2.37.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.26, a number that is poised to hit 1.04 in the next quarter and is forecasted to reach 4.14 in one year’s time.
